Your browser is no longer supported. Please, upgrade your browser.
Settings
TTOO T2 Biosystems, Inc. daily Stock Chart
TTOO [NASD]
T2 Biosystems, Inc.
Index- P/E- EPS (ttm)-1.28 Insider Own0.90% Shs Outstand46.56M Perf Week107.19%
Market Cap134.09M Forward P/E- EPS next Y-0.80 Insider Trans-5.30% Shs Float37.52M Perf Month285.23%
Income-56.70M PEG- EPS next Q-0.31 Inst Own38.70% Short Float17.24% Perf Quarter63.64%
Sales7.80M P/S17.19 EPS this Y35.10% Inst Trans-15.86% Short Ratio3.38 Perf Half Y7.46%
Book/sh-0.35 P/B- EPS next Y31.00% ROA-94.20% Target Price7.22 Perf Year-54.72%
Cash/sh0.61 P/C4.72 EPS next 5Y- ROE- 52W Range0.52 - 7.70 Perf YTD-4.32%
Dividend- P/FCF- EPS past 5Y3.80% ROI-83.80% 52W High-62.60% Beta1.43
Dividend %- Quick Ratio0.50 Sales past 5Y108.60% Gross Margin- 52W Low453.85% ATR0.28
Employees153 Current Ratio0.60 Sales Q/Q-53.80% Oper. Margin- RSI (14)77.20 Volatility24.06% 16.37%
OptionableYes Debt/Eq- EPS Q/Q-9.40% Profit Margin- Rel Volume2.35 Prev Close3.01
ShortableYes LT Debt/Eq- EarningsOct 29 AMC Payout- Avg Volume1.91M Price2.88
Recom2.00 SMA20105.43% SMA50117.43% SMA20011.42% Volume4,499,125 Change-4.32%
Aug-01-19Downgrade Alliance Global Partners Buy → Neutral
Jul-31-19Downgrade Janney Buy → Neutral
Jul-31-19Downgrade H.C. Wainwright Buy → Neutral
May-16-19Initiated Alliance Global Partners Buy $5
Mar-08-19Reiterated H.C. Wainwright Buy $14 → $11
Jun-01-18Upgrade Leerink Partners Mkt Perform → Outperform
May-30-18Reiterated H.C. Wainwright Buy $8.50 → $14
May-29-18Reiterated WBB Securities Strong Buy $12 → $20
Mar-29-18Reiterated H.C. Wainwright Buy $8 → $8.50
Jan-29-18Initiated Goldman Neutral $5.20
Oct-18-17Initiated H.C. Wainwright Buy $8
Mar-15-17Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-10-16Resumed Leerink Partners Mkt Perform $5
Nov-02-16Reiterated Cantor Fitzgerald Buy $10 → $9
Jul-20-16Upgrade WBB Securities Buy → Strong Buy $11 → $12
Jun-22-16Upgrade WBB Securities Speculative Buy → Buy $11
Apr-12-16Reiterated Canaccord Genuity Buy $13 → $12
Feb-17-16Initiated WBB Securities Speculative Buy $11
Feb-10-16Initiated Cantor Fitzgerald Buy $15
Sep-13-19 04:39AM  2 Downtrodden Small Biotechs That Are Showing Signs of Life TheStreet.com
Sep-11-19 03:11PM  Shares of T2 Biosystems rise on federal contract for diagnostic tests American City Business Journals +82.52%
09:30AM  T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections GlobeNewswire
Sep-10-19 04:21PM  T2 Biosystems to Host Conference Call to Discuss Awarding of Multi-Million Dollar BARDA Contract GlobeNewswire
04:14PM  T2 Biosystems Announces Restructuring of CRG Term Loan Agreement GlobeNewswire
04:05PM  T2 Biosystems Awarded Breakthrough Technology Contract with Premier Inc. GlobeNewswire
Aug-30-19 11:32AM  How Much is T2 Biosystems, Inc.'s (NASDAQ:TTOO) CEO Getting Paid? Simply Wall St. -11.33%
Aug-29-19 07:30AM  T2 Biosystems to Present at the Janney Healthcare Conference 2019 GlobeNewswire +7.14%
Aug-28-19 09:03AM  Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock? Zacks
Aug-26-19 07:42AM  4 Defensible Healthcare Stocks Gaining While the Market Falls TipRanks +11.76%
Aug-16-19 07:30AM  T2 Biosystems Expands Access to its Innovative Rapid Diagnostic Technologies to Australia, Fiji and New Zealand GlobeNewswire
Aug-14-19 04:30PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire -7.72%
Aug-06-19 07:30AM  T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS GlobeNewswire +20.41%
Aug-03-19 02:08PM  Edited Transcript of TTOO earnings conference call or presentation 30-Jul-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-02-19 04:53AM  Swinging for the Small-Cap Biotech Fences Requires Accepting Strikeouts TheStreet.com +5.45%
Jul-31-19 10:31AM  Lexington diagnostics maker T2 Biosystems' stock plummets on CEO departure, low earnings American City Business Journals -59.03%
07:06AM  The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster Benzinga
Jul-30-19 06:45PM  T2 Biosystems (TTOO) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:01PM  T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  T2 Biosystems, Inc. to Host Earnings Call ACCESSWIRE
07:30AM  T2 Biosystems to Present at the Canaccord Genuity Growth Conference GlobeNewswire
Jul-26-19 07:30AM  T2 Biosystems Expands Global Access to its Innovative Rapid Diagnostic Technologies GlobeNewswire
Jul-24-19 07:30AM  T2 Biosystems Announces 2019 Second Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Jul-16-19 10:03AM  Before You Buy T2 Biosystems, Inc. (NASDAQ:TTOO), Consider Its Volatility Simply Wall St. +10.32%
Jul-03-19 07:30AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Jun-28-19 07:30AM  T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts GlobeNewswire +7.01%
Jun-20-19 07:30AM  T2 Biosystems Introduces New Clinical Data and Updates Regarding Expanding Capabilities of its Rapid Diagnostic Technology at ASM Microbe 2019 GlobeNewswire
Jun-17-19 07:30AM  T2 Biosystems Highlights Current and Future Opportunities for its Breakthrough Rapid Diagnostic Technology for Biothreat Pathogen Detection GlobeNewswire
Jun-12-19 07:30AM  T2 Biosystems to Highlight its Products and Technology at Upcoming Medical Meetings GlobeNewswire +8.92%
Jun-10-19 01:06PM  Do Institutions Own T2 Biosystems, Inc. (NASDAQ:TTOO) Shares? Simply Wall St.
07:30AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Jun-06-19 07:30AM  New Studies Highlight Potential for T2Bacteria and T2Candida Panels to Improve Outcomes and be Cost-Effective for Sepsis Patients in the Medical Intensive Care Unit and Emergency Department GlobeNewswire
May-24-19 07:30AM  T2 Biosystems to Participate in Singular Research Spring Select Web Call GlobeNewswire
May-23-19 11:08AM  Robust Clinical Data and Positive Customer Experience with T2Bacteria and T2Candida Panels Highlighted at Recent Medical Meetings GlobeNewswire -19.07%
May-14-19 07:00AM  Publication in Annals of Internal Medicine® Reveals T2Bacteria® Panel as the First Direct-from-Blood, Non-Culture Test that Rapidly Diagnoses Bacterial Bloodstream Infections GlobeNewswire
May-13-19 04:30PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
May-08-19 02:45PM  T2 Biosystems to Showcase Breakthrough Rapid Diagnostics During 22nd Annual MAD-ID Meeting in Orlando, Florida GlobeNewswire
May-07-19 05:52PM  Edited Transcript of TTOO earnings conference call or presentation 2-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-02-19 06:55PM  T2 Biosystems (TTOO) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:47PM  T2 Biosystems: 1Q Earnings Snapshot Associated Press
04:01PM  T2 Biosystems Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Apr-29-19 09:41AM  Can Mass Cytometry Drive Fluidigm's (FLDM) Q1 Earnings? Zacks
09:25AM  Integer Holdings (ITGR) Q1 Earnings: What's in the Cards? Zacks
Apr-25-19 10:33AM  T2 Biosystems (TTOO) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Apr-18-19 04:30PM  T2 Biosystems Announces 2019 First Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
12:14PM  Will T2 Biosystems, Inc.'s (NASDAQ:TTOO) Earnings Grow In The Years Ahead? Simply Wall St.
Apr-08-19 04:30PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire +12.73%
Apr-03-19 07:30AM  T2 Biosystems to Present at the 18th Annual Needham Healthcare Conference GlobeNewswire
Mar-27-19 12:18AM  Edited Transcript of TTOO earnings conference call or presentation 7-Mar-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-13-19 12:00PM  T2 Biosystems, Inc.s (NASDAQ:TTOO) Shift From Loss To Profit Simply Wall St.
Mar-07-19 04:01PM  T2 Biosystems Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update GlobeNewswire
08:45AM  Is the Options Market Predicting a Spike in T2 Biosystems (TTOO) Stock? Zacks
Mar-01-19 08:30AM  3 Recent Big Gainers Kick Off the Dramatic Return of 'Small-Cap Friday' TheStreet.com
Feb-28-19 08:24AM  The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems Benzinga +15.43%
Feb-27-19 04:01PM  FDA Grants T2 Biosystems Breakthrough Device Designation for the T2Resistance Panel; Expected Availability through CE Mark in 2019 GlobeNewswire -5.05%
Feb-26-19 07:30AM  Detailed Research: Economic Perspectives on Altice, Just Energy Group, Ultra Petroleum, RadNet, T2 Biosystems, and Calumet Specialty Products Partners What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-21-19 07:30AM  T2 Biosystems to Present at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-20-19 04:30PM  T2 Biosystems Announces 2018 Fourth Quarter and Full Year Financial and Operational Results Release and Conference Call Date GlobeNewswire
12:00PM  Fast Company Names T2Biosystems One of the Worlds Most Innovative Companies For Battling Sepsis in Hours not Days GlobeNewswire
Feb-07-19 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire -12.66%
Jan-23-19 07:00AM  T2 Biosystems to Participate in Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria GlobeNewswire
Jan-18-19 11:50AM  Our Take On T2 Biosystems, Inc.s (NASDAQ:TTOO) CEO Salary Simply Wall St.
Jan-08-19 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Dec-20-18 09:41AM  Is T2 Biosystems Inc (TTOO) Going to Burn These Hedge Funds? Insider Monkey
Dec-07-18 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Nov-29-18 07:45AM  New Research: Key Drivers of Growth for Upland Software, VICI Properties, Sage Therapeutics, Jack Henry & Associates, T2 Biosystems, and Tata Motors Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Nov-13-18 11:41AM  How Many T2 Biosystems Inc (NASDAQ:TTOO) Shares Do Institutions Own? Simply Wall St.
Nov-12-18 03:26PM  Edited Transcript of TTOO earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents
08:40AM  Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems Zacks
Nov-09-18 06:47AM  Bet on Rising P/E Investing With These 5 Top-Ranked Stocks Zacks
Nov-08-18 07:00AM  T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum GlobeNewswire
Nov-07-18 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Nov-01-18 05:30PM  T2 Biosystems: 3Q Earnings Snapshot Associated Press
04:01PM  T2 Biosystems Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Oct-22-18 07:20AM  Consolidated Research: 2018 Summary Expectations for Vuzix, BCE, Tetraphase Pharmaceuticals, T2 Biosystems, TPG Specialty Lending, and Jianpu Technology Fundamental Analysis, Key Performance Indications GlobeNewswire +11.39%
Oct-18-18 07:00AM  T2 Biosystems Announces 2018 Third Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Oct-05-18 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Oct-03-18 07:00AM  T2 Biosystems Announces Customer Presentations at October Conferences GlobeNewswire
Sep-26-18 04:56PM  Here's Why T2 Biosystems Rose as Much as 16% Today Motley Fool +9.69%
07:00AM  New Data Suggests T2 Biosystems T2Lyme Panel is More Accurate than Other Diagnostics for Identifying Borrelia Infections for Patients Suspected of Having Early Lyme Disease GlobeNewswire
Sep-10-18 07:00AM  T2 Biosystems to Participate in Two Upcoming Investor Conferences GlobeNewswire
Sep-07-18 01:33PM  Should T2 Biosystems Incs (NASDAQ:TTOO) Recent Earnings Worry You? Simply Wall St. +5.64%
07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Aug-13-18 11:40PM  Edited Transcript of TTOO earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-06-18 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire +13.81%
Aug-02-18 05:39PM  T2 Biosystems: 2Q Earnings Snapshot Associated Press
04:01PM  T2 Biosystems Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Jul-24-18 07:00AM  T2 Biosystems to Participate in Two Upcoming Conferences GlobeNewswire -6.99%
Jul-20-18 07:00AM  T2 Biosystems Announces 2018 Second Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Jul-09-18 04:15PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Jun-29-18 07:05AM  Free Stock Performance Review on Thermo Fisher Scientific and Three Additional Medical Research Stocks ACCESSWIRE
Jun-25-18 07:00AM  T2 Biosystems Added to the Russell 3000® Index GlobeNewswire
Jun-13-18 07:00AM  Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018 GlobeNewswire
Jun-08-18 04:04PM  Edited Transcript of TTOO earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents +11.35%
Jun-06-18 10:08AM  Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2018 PR Newswire
07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Jun-05-18 07:00AM  T2 Biosystems Announces Closing of Public Offering of Common Stock GlobeNewswire
Jun-03-18 10:00AM  How to Manage Risk in Biotech Stocks TheStreet.com
Jun-01-18 02:54PM  Here's Why T2 Biosystems, Inc. Rose Over 16% Today Motley Fool +10.53%
07:00AM  T2 Biosystems to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company also offers T2Dx, a bench-top instrument for detecting pathogens associated with sepsis and Lyme disease, and other applications, as well as T2Candida panel that identifies the species of Candida, a fungal pathogen known to cause sepsis directly from whole blood. In addition, it is developing Candida Auris, a multi-drug resistant pathogen; T2Bacteria, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; and T2Lyme for the detection of various strains of Lyme disease-causing bacteria. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease; and Allergan Sales, LLC to develop detection diagnostic test panel that adds one additional bacteria species to the existing T2Bacteria product candidate, as well as for testing drug resistance directly in whole blood. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barclay AlecSVP, OperationsSep 11Sale2.924,21012,29342,102Sep 13 06:05 AM
Cima Michael J.DirectorJun 11Sale1.433,2404,633213,178Jun 13 04:31 PM
CUMMING JOHN WDirectorJun 11Sale1.433,4204,89123,580Jun 13 04:30 PM
Lapidus StanleyDirectorJun 11Sale1.449,00012,96053,010Jun 13 04:30 PM
Elsbree David BDirectorJun 11Sale1.443,6005,18483,108Jun 13 04:30 PM
Lowery Thomas J.Chief Scientific OfficerFeb 11Sale3.363,00510,09769,704Feb 12 04:52 PM
Gibbs Michael TerrenceGeneral CounselFeb 11Sale3.363,00510,09757,237Feb 12 04:51 PM
McDonough JohnPresident & CEOFeb 11Sale3.368,13427,330448,220Feb 12 04:47 PM
Lowery Thomas J.Chief Scientific OfficerFeb 01Sale3.474,18514,52266,875Feb 05 04:53 PM
McDonough JohnPresident & CEOFeb 01Sale3.479,44332,767439,688Feb 05 04:54 PM
Gibbs Michael TerrenceGeneral CounselFeb 01Sale3.471,8206,31554,428Feb 05 04:55 PM
Gibbs Michael TerrenceGeneral CounselJan 31Sale3.359393,14656,248Feb 05 04:55 PM
McDonough JohnPresident & CEOJan 31Sale3.354,89516,398449,131Feb 05 04:54 PM
Lowery Thomas J.Chief Scientific OfficerJan 31Sale3.352,1667,25671,060Feb 05 04:53 PM
Lapidus StanleyDirectorNov 06Option Exercise1.1627,05831,38759,058Nov 08 02:05 PM
Lapidus StanleyDirectorNov 06Sale5.296,04831,99453,010Nov 08 02:05 PM
Lowery Thomas J.Chief Scientific OfficerSep 20Option Exercise3.2248,205155,22091,431Sep 21 04:00 PM
Lowery Thomas J.Chief Scientific OfficerSep 20Sale6.1848,205297,90743,226Sep 21 04:00 PM
Lowery Thomas J.Chief Scientific OfficerSep 19Option Exercise2.9537,902111,95481,128Sep 20 06:26 PM
Lowery Thomas J.Chief Scientific OfficerSep 19Sale6.2037,902234,99243,226Sep 20 06:26 PM
Lowery Thomas J.Chief Scientific OfficerSep 18Option Exercise1.90100,242190,824143,468Sep 20 06:26 PM
Lowery Thomas J.Chief Scientific OfficerSep 18Sale6.17100,242618,05443,226Sep 20 06:26 PM